Delivery formulations

Roquette and Qualicaps combine to expand global footprint

08-Dec-2023 By Liza Laws

Pharma and plant-based ingredient giant, Roquette, has confirmed its acquisition of Qualicaps from the Mitsubishu Chemical Group.

Symbiosis Pharmaceutical Services granted MHRA license following £1 million investment

07-Dec-2023 By Liza Laws

Symbiosis Pharmaceutical Services can now test small molecule, biological and advanced therapeutical medicinal products (ATMP) following a £1 million investment.

Piramal Pharma has launched a high-throughput screening facility

06-Dec-2023 By Liza Laws

Piramal Pharma has launched a high-throughput screening facility at its drug discovery services site in Ahmedabad, India.

Lilly's plans for $2.5 billion site in Germany to expand injectable manufacturing capacity

06-Dec-2023 By Liza Laws

Eli Lilly has invested in its manufacturing capacity once more and has announced plans to build a $2.5 billion high-tech manufacturing site in Germany.

CellCentric's new ways to treat specific blood cancers published in Cancer Cell journal

22-Nov-2023 By Liza Laws

A cornerstone paper published in peer-reviewed scientific journal, Cancer Cell, has demonstrated a new way to treat specific blood cancers.

Pfizer's first acute migraine treatment recommended by NICE

28-Sep-2023 By Liza Laws

The first treatment for acute migraine made by Pfizer Ltd has been recommended by the National Institute for Health and Care Excellence (NICE).

GSK’s Ojjaara approved by FDA for patients with blood cancer and anemia

18-Sep-2023 By Jonathan Smith

The small molecule drug Ojjaara (momelotinib), developed by GlaxoSmithKline, has become the first U.S. Food and Drug Administration (FDA)-approved treatment for patients with the blood cancer myelofibrosis and anemia.

Calliditas Therapeutics advances kidney disease drug, meeting primary endpoint in study

15-Aug-2023 By Liza Laws

Calliditas Therapeutics AB’s phase 3 study looking at a cure for a kidney disease called IgA nephropathy (IgAN) has met its primary endpoint and the full data has been published in The Lancet.

Citius reaches 92 milestone events in phase 3 catheter-related bloodstream infections trial

14-Aug-2023 By Liza Laws

Patients suffering from catheter-related bloodstream infections could be treated with Citius Pharmaceuticals antibiotic lock solution after it achieved 92 milestone events in its phase 3 trial.

Soft mist inhaler for PAH result of joint venture between Thaerapy and Resyca

19-Jun-2023 By Liza Laws

A soft mist inhaler made by Resyca BV, a joint venture of Medspray Pharma BV and Recipharm AB, is being brought to patients with pulmonary arterial hypertension (PAH).

CorMedix on track to put an end to infection misery for dialysis patients

08-Jun-2023 By Liza Laws

An antifungal and antimicrobial solution could put an end to the discomfort of infection that many patients with kidney disease often endure.

Health authority approval given to Omya for API production

27-Apr-2023 By Liza Laws

Swiss company Omya’s production site in Kemalpaşa, Turkey, has gained health authority approval to produce GMP-compliant pharmaceutical ingredients.

Roquette opens $25m US oral dosage innovation center

24-Apr-2023 By Ben Hargreaves

The French company announces the opening of its facility, and the hiring of research scientists and formulation specialists that will staff the site.

Chiesi sponsors provider of US lab spaces for networking potential

24-Apr-2023 By Ben Hargreaves

Chiesi partners with BioLabs to gain access to certain sites and work with the companies using the facilities to advance rare disease research.

Self-testing at home kits cut waiting time and ease pressure on health services, 2San says

18-Apr-2023 By Liza Laws

Diagnostic and digital tools company, 2San, has been listed with LLoydsPharmacy to offer seven health tests customers can do at home.

Interview: How to avoid unnecessary legwork and data scraping with Aerona's modern approach across pharma divisions

18-Apr-2023 By Liza Laws

Aerona Clinical is a medium sized pharmaceutical company, represented not only in the United Kingdom, but in Europe, and with a global reach. The company has been operating in this environment in the pharma industry for 15 to 20 years.

Taros and Welab combine to provide discovery and development services

17-Apr-2023 By Ben Hargreaves

The German and Spanish companies use their relevant expertise in conjunction to provide clients with services spanning from hit generation to pre-clinical development.

Phlow raises funds to expand its CDMO capabilities

12-Apr-2023 By Ben Hargreaves

The CDMO completes a Series B capital raise, and it will use the funds generated to broaden its commercial offerings through its cdmoX program.

Avacta opens two US sites and doses first patient in sarcoma drug trial

06-Apr-2023 By Liza Laws

TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.

Mixed results from latest study of BenevolentAI's dermatitis ointment

06-Apr-2023 By Liza Laws

An ointment for patients with mild to moderate skin disease, atopic dermatitis (AD), has had mixed results from its phase 2a study.

FDA grants approval for OTC opioid overdose treatment

03-Apr-2023 By Ben Hargreaves

The naloxone hydrochloride nasal spray will be made available over-the-counter, therefore not requiring a prescription, in an effort to reduce deaths from opioid abuse.

Cingulate and Indegene announce agreement for lead ADHD drug - the first of its kind

31-Mar-2023 By Liza Laws

An agreement has been reached to promote Cingulate Inc’s ‘first true entire active day medication’ designed to treat attention deficit hyperactivity disorder (ADHD).

Hovione and Laxxon partner on 3D printed pharmaceuticals

27-Mar-2023 By Ben Hargreaves

The two companies enter into a long-term partnership to advance 3D screen printing technologies for applications within the pharma industry.

AbbVie receives CRL over drug delivery device

27-Mar-2023 By Ben Hargreaves

The US FDA demanded more information about the device, which would deliver ABBV-951 to patients, should the treatment be approved.

Zebra adds new environmental sensors for pharma supply chain

23-Mar-2023 By Ben Hargreaves

The company launches its new ZS300 sensor, ZB200 bridge and Android sensor discovery app, which will be made available for use with the supply chains of the pharma and food industries.

Vaxart reduces workforce and pauses COVID-19 vaccine development

20-Mar-2023 By Ben Hargreaves

The developer of oral vaccines announces a restructure of its business priorities, as it looks to conserve cash to progress its norovirus candidate.

EDSA outlines supply danger to 100 medicines after manufacturer bankruptcy

20-Mar-2023 By Ben Hargreaves

Earlier this year, Akorn Pharmaceuticals fell into bankruptcy, and now an alliance of stakeholders have released a report outlining potential supply disruption to a number of medications.

Bluepharma invests €30M in industrial unit for oncology drugs

20-Mar-2023 By Liza Laws

Portuguese pharma company, Bluepharma, has opened an industrial unit specializing in producing oral solid, high potent drugs in the oncology area.

CatSci Ltd and AGC Pharma Chemicals announce their strategic partnership

16-Mar-2023 By Liza Laws

Medicine developer, CatSci Ltd announced yesterday (March 15) that it has formed a new partnership with AGC Pharma Chemicals, a small molecule Contract Development and Manufacturing Organisation (CDMO).

LG Chem targets becoming top 20 oncology company

14-Mar-2023 By Ben Hargreaves

After completing the acquisition of Aveo, the Korean chemical company wants its subsidiary to become a global leader in the therapeutic area within five years.

Janssen dual action tablet for prostate cancer gets recommended marketing authorization

13-Mar-2023 By Liza Laws

Small molecule drug, Niraparib combined with abiraterone acetate (AA) and prednisone (P) significantly reduces the risk of disease progression, or death, in patients with a type of prostate cancer, a consultant in Spain has said.

TandemAI gets rolling with $35m in financing

07-Mar-2023 By Ben Hargreaves

The Chinese company is working on a drug discovery platform utilizing AI, and managed to secure funds to progress its business.

ObvioHealth reveals new multitasking digital therapeutics API

23-Feb-2023 By Liza Laws

With the ongoing digital shift in clinical trials, companies are continuously striving to improve both patient experience and clinical data quality.

Pasithea agrees manufacturing deal with WuXi STA

24-Jan-2023 By Ben Hargreaves

The CDMO will manufacture the API for the biotech’s lead drug candidate, ahead of plans to begin clinical trials.

Eurofins relocates to expand API capabilities in Canada

17-Jan-2023 By Ben Hargreaves

Eurofins announces that it relocated and expanded its API development laboratories by moving to a new space in Ontario, Canada.

CPHI Pharma Award finalists announced

26-Oct-2022

The awards cover innovations spanning the full pharmaceutical supply chain and feature many of pharma’s biggest names and breakthrough companies.

Ensysce teams up with Quotient to develop opioid that prevents abuse, overdose

12-Sep-2022 By Nick Taylor

Ensysce Biosciences has partnered with Quotient Sciences to develop an opioid to prevent abuse and overdose, enabling it to make mid-study changes to the formulation based on emerging data.

Precision delivery device offers hope for menstrual migraine patients

08-Sep-2022 By Jenni Spinner

Impel Pharmaceuticals’ Trudhesa treatment, paired with its Precision Olfactory Delivery system, reportedly shows promise to women suffering from the condition.

Vaderis exits stealth as ex-Almac Discovery candidate enters clinical development

07-Sep-2022 By Nick Taylor

The clinical-stage biotechnology company is working on the advancement of a treatment for a blood vessel disorder that it licensed from the other company

People on the Move: September 2022

01-Sep-2022 By Jenni Spinner

This month’s announcements of appointments, acquisitions, new hires, and other news include Standigm, Astellas Pharma, Trialbee, and other key companies.

Market demands, trends impacting APIs and excipients: MilliporeSigma

31-Aug-2022 By Jenni Spinner

An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.

Synthetic bio company Antheia raises $40m, announces new pilot plant

31-Aug-2022 By Jenni Spinner

The synthetic biology company which specializes in producing ingredients for plant-inspired medicines has a pilot-scale manufacturing facility in the works.

Syneos joins with physIQ, InCarda on atrial fibrillation study

30-Aug-2022 By Jenni Spinner

The physIQ monitoring platform will be used to evaluate an inhaled treatment, developed by InCarda, that is intended to treat atrial fibrillation patients.

Cutting ‘pain points’ can streamline chemical reporting: ACD/Labs

30-Aug-2022 By Jenni Spinner

A representative from the R&D tech provider offers advice on how to wrangle with a stressful, complicated process for better results and fewer headaches.

Celanese lands Gates Foundation grant for refillable contraceptive research

29-Aug-2022 By Jenni Spinner

The company has landed funding from the Bill and Melinda Gates Foundation for research and development on a prototype of a refillable contraceptive solution.

Impel Pharmaceuticals reports progress with ASD-related drug trial

29-Aug-2022 By Jenni Spinner

The company reports dosing of the first subject in a Phase IIa proof-of-concept study investigating a drug for an autism spectrum disorder related condition.

Outsourcing strategists thinking farther ahead than ever: CPHI

23-Aug-2022 By Jenni Spinner

The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.

Auransa, Polaris harness AI, quantum computing to discover cancer drugs

16-Aug-2022 By Jenni Spinner

The AI and QC specialists have joined to use AI and QC in order to discover biological pathways relevant to the treatment of triple-negative breast cancer.

Merck partners with Cerevance on Alzheimer’s research initiative

11-Aug-2022 By Jenni Spinner

The pharmaceutical company has inked a strategic collaboration with the drug discovery firm, centering on uncovering novel targets in Alzheimer’s disease.

J&J, Evotec partner on ectodomain shedding drug discovery project

11-Aug-2022 By Jenni Spinner

Janssen has formed a strategic collaboration with the drug discovery specialist that involves applying TargetAlloMod platforms to protein homeostasis.